Profil
Mr. Jeremy P.
Goldberg is an Advisor at Sixth Street Advisors LLC (Private Equity), a Senior Advisor at Arsenal Capital Management LP and an Advisor at Riverside Partners LLC.
Mr. Goldberg was previously employed as an Advisor by Torreya Partners LLC, a Managing Director, Corporate Development by Endo Pharmaceuticals, Inc., a Partner by ProQuest Investments (Canada), and a Founder and President, Versicor by Sunovion Pharmaceuticals, Inc. He received his undergraduate degree from Harvard University and an MBA from Harvard Business School.
Postes actifs de Jeremy Goldberg
| Sociétés | Poste | Début |
|---|---|---|
Riverside Partners LLC
Riverside Partners LLC Investment ManagersFinance Riverside Partners invests in middle-market companies located in the United States primarily in North America with an EBITDA of USD 3 - 15 million. The firm focuses on technology and healthcare sectors. It participates in buyouts, recapitalizations, growth equity, divestitures, take private transactions and strategic add-on acquisitions. It makes control investments. | Consultant / Advisor | - |
Arsenal Capital Management LP
Arsenal Capital Management LP Investment ManagersFinance Arsenal Capital invests in middle market companies located in the United States. The firm focuses on healthcare and industrial sectors. It participates in buyouts, add-on acquisitions and growth stage capital transactions. | Private Equity Investor | 01/04/2014 |
TPG Sixth Street Partners LLC
TPG Sixth Street Partners LLC Investment ManagersFinance Sixth Street TAO invests in middle-market and large-cap public and private companies located across the globe. The firm targets companies operating across a broad range of sectors and industries. It provides financing for later stage, growth, buyout, infrastructure, special situations and recapitalization in the form of equity and debt with an investment size of USD 50 million - 2.5 billion. The firm also acquires minority and majority interests. It also makes follow-on investments. | Consultant / Advisor | 01/05/2016 |
Anciens postes connus de Jeremy Goldberg
| Sociétés | Poste | Fin |
|---|---|---|
Torreya Partners LLC
Torreya Partners LLC Investment ManagersFinance Provides financial advisory services | Consultant / Advisor | 01/05/2017 |
Endo Pharmaceuticals, Inc.
Endo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Corporate Officer/Principal | 01/01/2008 |
ProQuest Management LLC (Canada)
ProQuest Management LLC (Canada) Investment ManagersFinance ProQuest invests in healthcare companies from seed to late-stage. They have special expertise in therapeutics. ProQuest looks for companies and technologies with the potential to become substantial, sustainable enterprises. Companies should have strong intellectual property. The firm targets companies with breakthrough technology and products, proven management, large market potential and a realizable business strategy. ProQuest focuses on opportunities in initial addressable markets of at least $200 million where there is a significant unmet need for the company's products and technology. Average investments range from $250,000 to $25 million. | Private Equity Investor | 01/01/2002 |
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals for oncology, CNS, urology and rare diseases | Fondateur | 01/01/1997 |
Formation de Jeremy Goldberg
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals for oncology, CNS, urology and rare diseases | Health Technology |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Endo Pharmaceuticals, Inc.
Endo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
Arsenal Capital Management LP
Arsenal Capital Management LP Investment ManagersFinance Arsenal Capital invests in middle market companies located in the United States. The firm focuses on healthcare and industrial sectors. It participates in buyouts, add-on acquisitions and growth stage capital transactions. | Finance |
Riverside Partners LLC
Riverside Partners LLC Investment ManagersFinance Riverside Partners invests in middle-market companies located in the United States primarily in North America with an EBITDA of USD 3 - 15 million. The firm focuses on technology and healthcare sectors. It participates in buyouts, recapitalizations, growth equity, divestitures, take private transactions and strategic add-on acquisitions. It makes control investments. | Finance |
ProQuest Management LLC (Canada)
ProQuest Management LLC (Canada) Investment ManagersFinance ProQuest invests in healthcare companies from seed to late-stage. They have special expertise in therapeutics. ProQuest looks for companies and technologies with the potential to become substantial, sustainable enterprises. Companies should have strong intellectual property. The firm targets companies with breakthrough technology and products, proven management, large market potential and a realizable business strategy. ProQuest focuses on opportunities in initial addressable markets of at least $200 million where there is a significant unmet need for the company's products and technology. Average investments range from $250,000 to $25 million. | Finance |
Torreya Partners LLC
Torreya Partners LLC Investment ManagersFinance Provides financial advisory services | Finance |
Harvard Business School
Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
TPG Sixth Street Partners LLC
TPG Sixth Street Partners LLC Investment ManagersFinance Sixth Street TAO invests in middle-market and large-cap public and private companies located across the globe. The firm targets companies operating across a broad range of sectors and industries. It provides financing for later stage, growth, buyout, infrastructure, special situations and recapitalization in the form of equity and debt with an investment size of USD 50 million - 2.5 billion. The firm also acquires minority and majority interests. It also makes follow-on investments. | Finance |
















